Documents > food and drug administration


Summary of H R - H.R. 3580, Food and Drug Administration Act of 2007

Reps 6/18/2008 | 0 (0) | 9 | 0 | 0 | English

SUMMARY H.R. ____, Food and Drug Administration Amendments Act of 2007 Title I. Prescription Drug User Fee Amendments of 2007 Title I reauthorizes the prescription drug user fee program through fiscal year (FY) 2012. Changes to the prescription drug user fee program fall into three major categories: enhancements to ensure sound financial footing fo ...  more>>

Public Health Service Food and Drug Adrninistrition Rockville

FDADocs 5/5/2008 | 0 (0) | 9 | 0 | 0 | English

Public Health Service Food and Drug Adrninistrition Rockville MD 20857 June 14, 2001 Mr. Andrew.N Gustafson, Ph.D. US Regulatory Affairs Vice President, GlaxoSmithKline Five Moore Drive Research Triangle Park, NC 27709 Dear Mr. Gustafson: Your petition requesting the Food and Drug Administration to reformat label was received by this offic ...  more>>

Review of the Food and Drug Administration's Cost Increase for the Arkansas Regional Laboratory, A-15-98-50002

HHS 6/19/2008 | 0 (0) | 9 | 0 | 0 | English

DEPARTMENT OF HEALTH & HUMAN SERVICES Office of Inspector General . Memorandum SEP - I 1999 Deputy Inspector General for Audit Services Review of the Food and Drug Administration’s Cost Increasefor the Arkansas Regional Laboratory (CIN: A-15-98-50002) JaneE. Henney, M.D. Commissioner Food and Drug Administration The attachedfi ...  more>>

Review of the Food and Drug Administration's Handling of Issues Related to Conjugated Estrogens, A-15-96-50002

HHS 6/19/2008 | 0 (0) | 9 | 0 | 0 | English

$ ~ 5 “+ �+.,a + % .L 4 *4+ ,* s[w’tct* ~ DEPARTMENT OF HEALTH& HUMAN SERVICES Offtce of Inspector General Memorandum A& Date MAY I 61997 Inspector Gener FromJune Gibbs Brown SubjectReview of the Foo and Drug Administration’s Handling of Issues Related to Conjugated 0“ Estrogens (A-1 5-96-50002) Michael A. Friedman, M.D. Lead Deputy C ...  more>>

Financial Audit of the Food and Drug Administration's Revolving Fund for Certification and Other Services, A-15-93-00007

HHS 6/19/2008 | 0 (0) | 9 | 0 | 0 | English

DEPARTMENT OF HEALTH 8a HUMAN SERVICES Office of inspector General Memorandum Date From Subject Bryan B. Mitchell &ad Principal Deputy Inspector General 7 Financial Audit of the Food and Drug Administration’s Revolving Fund for Certification and Other Services (A-15-93-7) Philip R. Lee, M.D. Assistant Secretary for Health , To The att ...  more>>

Follow-up Review of the Food and Drug Administration's Generic Drug Management Information System, A-15-91-00026

HHS 6/19/2008 | 0 (0) | 9 | 0 | 0 | English

. w I . - .d DEPARTMENT OF HEALTH 8a HUMAN SERVICES Dffice Iof General Date FIOITI . OCT 26 1992 Bryan B. Mitchell Principal Deputy Follow-up Review of the Food and Drug Administration's Generic Drug Management Information System (A-15-91-00026) James 0. Mason, M.D., Dr. P.H. Assistant Secretary for Health The attached final ...  more>>

Food and Drug Administration Live Satellite Teleconference

GovernmentDocs 5/5/2008 | 0 (0) | 9 | 0 | 0 | English

Food and Drug Administration Live Satellite Teleconference With FDA Commissioner Jane E. Henney, M.D. Wednesday, April 28, 1999 1-3 p.m. Eastern As part of the agency's ongoing conversation with stakeholders, Dr. Henney and Dr. Linda A. Suydam, Associate Commissioner for Strategic Management, were available to consumers, health providers, and indus ...  more>>

International Food Information Council Vol

FDADocs 5/5/2008 | 0 (0) | 9 | 0 | 0 | English

February 4,2003 Dockets Management Branch (HFA-305) Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, MD 20852 RE? 9444 ‘ 03 FEE-4 P4 25 Input to Docket No. 94P-0036, Food Labeling: Trans Fatty Acids in Nutrition Labeling, Nutrient Content Claims, and Health Claims: Reopening of the Comment Period The International Food Info ...  more>>

Review of the Annual Reporting Process for Investigational New Drugs Regulated by the Food and Drug Administration's Center for Biologics Evaluation and Research, A-15-96-50001

CMMSdocs 6/30/2008 | 0 (0) | 9 | 0 | 0 | English

‘“ “ . ‘* 4 JUL I 7 Memorandum June Gibbs Brown &L-Inspector General &” Review of the Annual Reporting Process for Investigational New Drugs Regulated by the Food and Drug Administration’s Center for Biologics Evaluation and Research (CIN: A-15-96-50001) Michael A. Friedman, M.D. Lead Deputy Commissioner Food and Drug Administration The attached  ...  more>>

Report of Review of the Food and Drug Administration's Internal Controls Over Its Purchase Card Activities, A-15-97-80002

CMMSdocs 6/30/2008 | 0 (0) | 9 | 0 | 0 | English

DEPARTMENT OF HEALTH & HUMAN SERVICES Office of Inspector General MAR - 2 1~ Date From Memorandum * Joseph J. Green Assistant Inspec for Public Health Service Audits Report of Review of the Food and Drug Administration’s Internal Controls Over Its Purchase Card Activities (A-15-97-80002) Robert J. Byrd Deputy Commissioner for Management a ...  more>>

Food and Drug Administraticm Roockville MD August Robert

FDADocs 5/5/2008 | 0 (0) | 8 | 0 | 0 | English

Food and Drug Administraticm Roockville MD 2X357 August 28, 2001 Robert W. Pollock Lachman Consultant Service, 1600 Stewart Avenue Westbury, New York 11590 Dear Mr. Pollock: Inc Your,petition requesting the Food and Drug Administration to determine that an abbreviated new drug application (ANDA)is permitted for Hydrocodone Bitartrate,and Acet ...  more>>

Report of Review of the Food and Drug Administration's Internal Controls Over Its Purchase Card Activities, A-15-97-80002

CMMSdocs 6/30/2008 | 0 (0) | 8 | 0 | 0 | English

DEPARTMENT OF HEALTH & HUMAN SERVICES Office of Inspector General MAR - 2 1~ Date From Memorandum * Joseph J. Green Assistant Inspec for Public Health Service Audits Report of Review of the Food and Drug Administration’s Internal Controls Over Its Purchase Card Activities (A-15-97-80002) Robert J. Byrd Deputy Commissioner for Management a ...  more>>


   
  results / page   15/25/50 Page: 28 of 34 << prev 1...25262728293031...34 next >>